Health · Under review · 2 sources combined
Obesity drugs gain dementia prevention attention
Effectiveness remains uncertain so far
In short
Obesity treatments like Wegovy and Mounjaro are being studied to see if they help prevent dementia and cancer.
Animal tests and some observational studies showed promise, but clear effects have not been confirmed in actual clinical trials.
Experts say the mechanism of action and long-term safety need further investigation.
Key facts
| When | The international journal Science published a special paper on November 5 (local time). |
|---|---|
| Who | A joint research team from University of Gothenburg in Sweden and University of Copenhagen in Denmark published a review article. |
| What | They comprehensively reviewed brain protection and dementia prevention potential of GLP-1 class obesity drugs. |
| How | Animal tests and some observational studies showed associations, but clinical trials have not proven the effect. |
What it means for me
If you take or are considering obesity drugs, note that dementia prevention effects are not yet established.
Seniors should be cautious as rapid weight loss can reduce muscle mass and worsen physical function.
